Dose adjustment strategy of levetiracetam in pregnant patients with epilepsy: Case report and literature review – PubMed Black Hawk Supplements

BLACK HAWK: High quality shilajit supplement for sexual health

Published article

RATIONALE: Pregnant patients with epilepsy are prone to preterm delivery, stillbirth, or cesarean section, and their mortality rate is almost 10 times higher than that of normal pregnant women. The potential negative influences of antiepileptic drugs (AEDs) on the fetus are weighed against the necessity for achieving optimal control of seizures. Treatment with AEDs during pregnancy is a major challenge for pregnant women and healthcare teams.
Black Hawk Supplements, best supplements in the UK

Dose adjustment strategy of levetiracetam in pregnant patients with epilepsy: Case report and literature review - PubMed

Review

Dose adjustment strategy of levetiracetam in pregnant patients with epilepsy: Case report and literature review

Renzhu Liu et al. Medicine (Baltimore). .

Abstract

Rationale: Pregnant patients with epilepsy are prone to preterm delivery, stillbirth, or cesarean section, and their mortality rate is almost 10 times higher than that of normal pregnant women. The potential negative influences of antiepileptic drugs (AEDs) on the fetus are weighed against the necessity for achieving optimal control of seizures. Treatment with AEDs during pregnancy is a major challenge for pregnant women and healthcare teams.

Patient concerns: This paper reports two cases of young women diagnosed with pregnancy and epilepsy.

Intervention: The dose of levetiracetam was adjusted under the guidance of therapeutic drug monitoring to reduce the effects of seizures on the fetus and the incidence of reproductive toxicity caused by adverse drug reactions.

Outcomes: Epilepsy was well controlled in the two pregnant patients, and the newborns had no genetic disorders.

Lessons: It is recommended to regularly monitor the serum LEV level in pregnant patients with epilepsy. This practice serves as a foundation for adjusting the drug treatment plan and offering more precise guidance for medication management during pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1

(A) Changes in serum concentration of different doses of levetiracetam in case 1 at different stages of pregnancy. (B) Changes in serum concentration of different doses of levetiracetam in case 2 at different stages of pregnancy.

Similar articles

References

    1. Tieu C, Breder CD. A critical evaluation of safety signal analysis using algorithmic standardised MedDRA Queries. Drug Saf. 2018;41:1375–85. – PubMed
    1. Katz O, Levy A, Wiznitzer A, et al. . Pregnancy and perinatal outcome in epileptic women: a population-based study. J Matern Fetal Neonatal Med. 2006;19:21–5. – PubMed
    1. MacDonald SC, Bateman BT, McElrath TF, et al. . Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States. JAMA Neurol. 2015;72:981–8. – PMC – PubMed
    1. Nucera B, Brigo F, Trinka E, et al. . Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide. Ther Adv Neurol Disord. 2022;15:17562864221101687. – PMC – PubMed
    1. Arpino C, Brescianini S, Robert E, et al. . Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia. 2000;41:1436–43. – PubMed

Publication types

MeSH terms

Substances

BLACK HAWK: Best lions mane supplement for teens

Read the original publication:

Dose adjustment strategy of levetiracetam in pregnant patients with epilepsy: Case report and literature review – PubMed